Allogene Therapeutics, Inc.

Analysis for Ticker: ALLO

Allogene Therapeutics Inc develops cancer therapies using cells from healthy donors, but the firm is a machine that runs on a subtraction problem. Imagine a baker who has never sold a single loaf of bread but has already lost 2,0$ billion of other people's money trying to find a recipe. This company survives by baking more and more slices out of the same pie and selling them to neighbors, which makes every existing slice smaller. The current math is a disaster because the insiders are eating the crumbs while the kitchen is still on fire, extracting millions in cash while the business has no actual sales to sustain itself.